View in EDS PDF Full Text

Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.

Saved in:
Bibliographic Details
Title: Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.
Authors: Sánchez-Pájaro, Andrés1, Barrera-Núñez, David A.1, Carnalla, Martha1, Mendoza-Alvarado, Laura Rosario2, Robles-Soto, Nadia, Ledesma-Torres, Lucía3, López-Olmedo, Nancy1, Fleiz-Bautista, Clara4, Reynales-Shigematsu, Luz Myriam1, Lazcano-Ponce, Eduardo5, Barrientos-Gutiérrez, Tonatiuh1 tbarrientos@insp.mx
Source: Salud Pública de México. nov/dec2025, Vol. 67 Issue 6, p777-784. 8p.
Subjects: DRUG abuse, PSYCHIATRIC drugs, TEENAGERS, DISEASE prevalence, COUNTRIES, HUMAN settlements
Geographic Terms: MEXICO
Abstract (English): Objective. To estimate the prevalence of illicit drug use and non-medical use of psychotropic medications among the Mexican population in 2023. Materials and methods. We used data from the 2023 Encuesta Nacional de Salud y Nutrición Continua. We constructed indicators for lifetime and past-year use. Prevalence estimates were calculated with 95% confidence intervals. Stratification was performed by age group, sex, and locality size. Results. The lifetime prevalence of illicit drug use was 14.1%. The most commonly used illicit drug was marijuana. The prevalence of non-medical use of psychotropic medications was 1.5%. Prevalence was higher among men and in urban areas. Conclusions. One in seven individuals has used an illicit drug at some point in their life. Past-year use has remained stable. The findings suggest an increase in experimental use, particularly among adolescents, young adults, and women. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Objetivo. Estimar la prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos sin indicación médica en población mexicana en 2023. Material y métodos. Se utilizó la Encuesta Nacional de Salud y Nutrición Continua 2023. Se construyeron indicadores de uso alguna vez en la vida y en el último año. Se estimó la prevalencia con intervalos de confianza al 95%. Se estratificó por grupo de edad, sexo y tamaño de la localidad. Resultados. La prevalencia de uso de drogas ilícitas alguna vez en la vida fue 14.1%. La droga ilícita más usada fue mariguana. La prevalencia de uso de medicamentos psicotrópicos sin indicación médica fue de 1.5%. Las prevalencias fueron más altas en hombres y en localidades urbanas. Conclusiones. Una de cada siete personas usó una droga ilícita alguna vez en su vida. El uso en el último año se ha mantenido constante. Los hallazgos sugieren un aumento del uso experimental, particularmente entre adolescentes, jóvenes y mujeres. [ABSTRACT FROM AUTHOR]
Copyright of Salud Pública de México is the property of Instituto Nacional de Salud Publica and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 190724733
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Sánchez-Pájaro%2C+Andrés%22">Sánchez-Pájaro, Andrés</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Barrera-Núñez%2C+David+A%2E%22">Barrera-Núñez, David A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Carnalla%2C+Martha%22">Carnalla, Martha</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Mendoza-Alvarado%2C+Laura+Rosario%22">Mendoza-Alvarado, Laura Rosario</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Robles-Soto%2C+Nadia%22">Robles-Soto, Nadia</searchLink><br /><searchLink fieldCode="AR" term="%22Ledesma-Torres%2C+Lucía%22">Ledesma-Torres, Lucía</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22López-Olmedo%2C+Nancy%22">López-Olmedo, Nancy</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fleiz-Bautista%2C+Clara%22">Fleiz-Bautista, Clara</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Reynales-Shigematsu%2C+Luz+Myriam%22">Reynales-Shigematsu, Luz Myriam</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lazcano-Ponce%2C+Eduardo%22">Lazcano-Ponce, Eduardo</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Barrientos-Gutiérrez%2C+Tonatiuh%22">Barrientos-Gutiérrez, Tonatiuh</searchLink><relatesTo>1</relatesTo><i> tbarrientos@insp.mx</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Salud+Pública+de+México%22">Salud Pública de México</searchLink>. nov/dec2025, Vol. 67 Issue 6, p777-784. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22DRUG+abuse%22">DRUG abuse</searchLink><br /><searchLink fieldCode="DE" term="%22PSYCHIATRIC+drugs%22">PSYCHIATRIC drugs</searchLink><br /><searchLink fieldCode="DE" term="%22TEENAGERS%22">TEENAGERS</searchLink><br /><searchLink fieldCode="DE" term="%22DISEASE+prevalence%22">DISEASE prevalence</searchLink><br /><searchLink fieldCode="DE" term="%22COUNTRIES%22">COUNTRIES</searchLink><br /><searchLink fieldCode="DE" term="%22HUMAN+settlements%22">HUMAN settlements</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MEXICO%22">MEXICO</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Objective. To estimate the prevalence of illicit drug use and non-medical use of psychotropic medications among the Mexican population in 2023. Materials and methods. We used data from the 2023 Encuesta Nacional de Salud y Nutrición Continua. We constructed indicators for lifetime and past-year use. Prevalence estimates were calculated with 95% confidence intervals. Stratification was performed by age group, sex, and locality size. Results. The lifetime prevalence of illicit drug use was 14.1%. The most commonly used illicit drug was marijuana. The prevalence of non-medical use of psychotropic medications was 1.5%. Prevalence was higher among men and in urban areas. Conclusions. One in seven individuals has used an illicit drug at some point in their life. Past-year use has remained stable. The findings suggest an increase in experimental use, particularly among adolescents, young adults, and women. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Objetivo. Estimar la prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos sin indicación médica en población mexicana en 2023. Material y métodos. Se utilizó la Encuesta Nacional de Salud y Nutrición Continua 2023. Se construyeron indicadores de uso alguna vez en la vida y en el último año. Se estimó la prevalencia con intervalos de confianza al 95%. Se estratificó por grupo de edad, sexo y tamaño de la localidad. Resultados. La prevalencia de uso de drogas ilícitas alguna vez en la vida fue 14.1%. La droga ilícita más usada fue mariguana. La prevalencia de uso de medicamentos psicotrópicos sin indicación médica fue de 1.5%. Las prevalencias fueron más altas en hombres y en localidades urbanas. Conclusiones. Una de cada siete personas usó una droga ilícita alguna vez en su vida. El uso en el último año se ha mantenido constante. Los hallazgos sugieren un aumento del uso experimental, particularmente entre adolescentes, jóvenes y mujeres. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Salud Pública de México is the property of Instituto Nacional de Salud Publica and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=190724733
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21149/16856
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 777
    Subjects:
      – SubjectFull: DRUG abuse
        Type: general
      – SubjectFull: PSYCHIATRIC drugs
        Type: general
      – SubjectFull: TEENAGERS
        Type: general
      – SubjectFull: DISEASE prevalence
        Type: general
      – SubjectFull: COUNTRIES
        Type: general
      – SubjectFull: HUMAN settlements
        Type: general
      – SubjectFull: MEXICO
        Type: general
    Titles:
      – TitleFull: Prevalencia de uso de drogas ilícitas y medicamentos psicotrópicos en México, Ensanut Continua 2023.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sánchez-Pájaro, Andrés
      – PersonEntity:
          Name:
            NameFull: Barrera-Núñez, David A.
      – PersonEntity:
          Name:
            NameFull: Carnalla, Martha
      – PersonEntity:
          Name:
            NameFull: Mendoza-Alvarado, Laura Rosario
      – PersonEntity:
          Name:
            NameFull: Robles-Soto, Nadia
      – PersonEntity:
          Name:
            NameFull: Ledesma-Torres, Lucía
      – PersonEntity:
          Name:
            NameFull: López-Olmedo, Nancy
      – PersonEntity:
          Name:
            NameFull: Fleiz-Bautista, Clara
      – PersonEntity:
          Name:
            NameFull: Reynales-Shigematsu, Luz Myriam
      – PersonEntity:
          Name:
            NameFull: Lazcano-Ponce, Eduardo
      – PersonEntity:
          Name:
            NameFull: Barrientos-Gutiérrez, Tonatiuh
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: nov/dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 00363634
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Salud Pública de México
              Type: main
ResultId 1